Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Warren Buffett's Berkshire Hathaway (NYSE:BRKa) disclosed its 13F filing for Q4 2024, revealing a notable investment in Constellation Brands (NYSE:STZ). The firm acquired 5.62 million Constellation shares, valued at $1.24 billion. Following the announcement, Constellation Brands stock surged 6% in after-hours trading, despite a 25.8% year-to-date decline.
Berkshire trimmed its stakes in major financial institutions. The company reduced its Citigroup (NYSE:C) holdings by 74%, lowering its position to 14.6 million shares. It also cut its Bank of America (NYSE:BAC) stake—formerly its second-largest holding—by 15%, bringing shares down to 680.2 million.
The report highlighted that Berkshire paused its Apple Inc (NASDAQ:AAPL) sell-off, maintaining 300 million shares, unchanged from Q3. This holding remains significantly lower than the 790 million shares owned at the end of 2023.
Additionally, Berkshire reduced its stake in DaVita HealthCare (NYSE:DVA) by approximately $32 million.
Investors closely monitor Berkshire's 13F filings, as Warren Buffett's long-term investment strategy influences market trends. Despite being 45 days old, the data offers insights into Berkshire's evolving portfolio and market outlook.
